67 studies found for:    Chest CT Scan | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Not yet recruiting Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed With Surgery
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Docetaxel;   Radiation: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Drug: Pemetrexed Disodium;   Procedure: Positron Emission Tomography
22 Recruiting SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
Conditions: Lung Carcinoma;   Malignant Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
23 Recruiting 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Conditions: Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoker
Interventions: Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
24 Recruiting Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF
Condition: Cystic Fibrosis
25 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
26 Recruiting Imaging Techniques in CT: Technical Development
Condition: Healthy Volunteers
27 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
28 Recruiting Links Between Inflammation and Cardiometabolic Diseases
Conditions: Diabetes Mellitus;   Cardiovascular Disease;   Healthy Volunteer;   Inflammation
29 Recruiting 18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: B-Cell Neoplasm;   Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Renal Cell Cancer;   Progesterone Receptor Negative;   Stage III Mesothelioma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Triple-Negative Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging
30 Recruiting An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast Asia
Conditions: Sepsis;   Severe Sepsis
31 Recruiting Cross-sectional Characterization of Idiopathic Bronchiectasis
Condition: Infection
32 Unknown  The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina
Condition: Angina
33 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
34 Recruiting Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)
Condition: Lung Cancer
35 Recruiting Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
Condition: Acute Myeloid Leukemia
36 Recruiting LMB-2 to Treat Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Intervention: Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
37 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC),;   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
38 Recruiting Pilot Trial of Allogeneic Blood or Marrow Transplanation for Primary Immunodeficiencies
Conditions: Primary T-cell Immunodeficiency Disorders;   Common Variable Immunodeficiency;   Immune System Diseases;   Autoimmune Lymphoproliferative;   Lymphoproliferative Disorders
Interventions: Drug: Immunosuppression Only Conditioning;   Drug: Reduced Intensity Conditioning;   Drug: Myeloablative Conditioning;   Drug: GVHD Prophylaxis;   Procedure: Allo BMT
39 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
40 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years